Hyaluronic%252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252520acid

# Hyaluronic acid ## Overview Hyaluronic acid (HA) is a naturally occurring glycosaminoglycan found in various tissues, including synovial fluid, skin, and eyes. It acts as a lubricant and a shock absorber. Pharmaceutical preparations are synthesized or derived from microbial fermentation. ## Primary Indications * **Intra-articular injection:** Osteoarthritis of the knee. * **Ophthalmic solution:** Ocular lubrication for dry eye disease, surgical aid during ophthalmic surgery. * **Dermal filler:** Aesthetic correction of facial wrinkles and folds. * **Wound healing:** Topical formulations for certain types of wounds. ## Adult Dosing * **Osteoarthritis of the knee:** * Typically administered as an intra-articular injection. * Common regimen: 2 mL (20 mg) injected once weekly for 3-5 weeks. * Some preparations may have different concentrations and frequencies (e.g., 4 mL (40 mg) for larger joints, or single-injection formulations). * Maximum dose: Varies by product and frequency. Consult specific product labeling. * **Ophthalmic solution (Dry Eye):** * 1-2 drops instilled into the affected eye(s) as needed, typically 3-4 times daily. * Preservative-free formulations may be used more frequently. * **Ophthalmic solution (Surgical Aid):** * Administered by an ophthalmic surgeon during procedures. Concentration and volume depend on the surgical technique. * **Dermal filler:** * Administered by a trained professional. Volume depends on the area treated and desired outcome. Typically ranges from 0.5 mL to several mL. * **Wound healing:** * Topical formulations (gels, dressings) applied as directed by the manufacturer or healthcare provider. ## Pediatric Dosing Dosing for hyaluronic acid in pediatric populations is **not well established** for most indications. Use in children, especially for intra-articular injections or dermal fillers, should be approached with caution and typically reserved for situations where benefits clearly outweigh risks, often under specialist guidance. Specific pediatric ophthalmic formulations may exist; consult product information. ## Dose Adjustments * **Renal or Hepatic Impairment:** No dose adjustments are typically required for systemic absorption is minimal with local administration. ## Contraindications * Known hypersensitivity to hyaluronic acid or any component of the formulation. * Infection or skin disease at or near the injection site for intra-articular or dermal filler use. * Active joint inflammation or effusion for intra-articular use. ## Adverse Effects * **Intra-articular:** Local pain, swelling, stiffness, transient joint effusion, transient inflammatory reaction. * **Ophthalmic:** Transient blurred vision, eye irritation, stinging, itching. Preservative-containing drops may cause conjunctival hyperemia or allergic reactions. * **Dermal filler:** Bruising, swelling, redness, itching, pain at the injection site. Rare but serious: infection, granuloma formation, vascular occlusion. * **Topical:** Local irritation, redness, or allergic reactions. ## Key Drug Interactions * **Intra-articular:** Concurrent use of corticosteroids may increase the risk of local side effects. Avoid intra-articular injections with other agents until local reaction subsides. * **Ophthalmic:** Generally minimal interactions. Allow 5-10 minutes between instillation of different ophthalmic drops. ## Monitoring * **Intra-articular:** Monitor for signs of infection (increased pain, redness, swelling, fever) or severe inflammatory reaction. Assess pain and function of the affected joint. * **Ophthalmic:** Monitor for symptom relief of dry eye or any signs of ocular irritation or infection. * **Dermal filler:** Monitor for cosmetic outcome and any signs of complications. ## Clinical Pearls * Hyaluronic acid preparations vary significantly in molecular weight, concentration, cross-linking (for fillers), and brand. Always refer to the specific product monograph for precise dosing, administration instructions, and contraindications. * For osteoarthritis, symptom relief may not be immediate and can take several weeks. Efficacy may vary among individuals. * Preservative-free ophthalmic formulations are preferred for frequent use or in patients with known sensitivities. * Dermal filler complications, while rare, can be serious. Ensure administration by a qualified and experienced healthcare professional. *** *Disclaimer: This information is intended for clinical use and does not replace professional medical advice. Always consult the most current prescribing information for any medication before use. Dosing and indications may vary based on specific product, patient factors, and local protocols.*